Curcumin and major depression / Adrian L. Lopresti en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.1 (Enero)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.1 (Enero) . - pp. 38-50 Título : Curcumin and major depression : A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change Tipo de documento: texto impreso Autores: Adrian L. Lopresti, Autor ; Michaël H.J. Maes, Autor ; Marcus J.M. Meddens, Autor Fecha de publicación: 2021 Artículo en la página: pp. 38-50 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Depresión, Curcumina, Biomarcadores, Cúrcuma, Ensayo clínico Resumen: A recent randomised, double-blind, placebo controlled study conducted by our research group, provided partial support for the efficacy of supplementation with a patented curcumin extract (500 mg, twice daily) for 8 weeks in reducing depressive symptoms in people with major depressive disorder. Link: ./index.php?lvl=notice_display&id=26843 [artículo] Curcumin and major depression : A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change [texto impreso] / Adrian L. Lopresti, Autor ; Michaël H.J. Maes, Autor ; Marcus J.M. Meddens, Autor . - 2021 . - pp. 38-50. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.1 (Enero) . - pp. 38-50 Palabras clave: Depresión, Curcumina, Biomarcadores, Cúrcuma, Ensayo clínico Resumen: A recent randomised, double-blind, placebo controlled study conducted by our research group, provided partial support for the efficacy of supplementation with a patented curcumin extract (500 mg, twice daily) for 8 weeks in reducing depressive symptoms in people with major depressive disorder. Link: ./index.php?lvl=notice_display&id=26843

---

1 (1 - 1 / 1)